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Background: Percutaneous coronary intervention (PCI) is often performed in patients with coronary artery disease (CAD) to improve outcome. The 
aim of this study was to evaluate clinical outcome for the different indications of PCI in a nation-wide PCI population. We investigated early, late and 
very late mortality after PCI, and clinical events that could contribute to the understanding of differences in mortality at the long term.
methods: We evaluated clinical outcome at short- and long term in all patients with CAD who underwent a PCI procedure for different indications 
in Sweden between January 2006 and December 2010. Patients were included only once and we adjusted for differences in baseline and procedural 
characteristics.
results: A total of 70,479 patients were treated for stable CAD (21.0%), unstable angina (11.0%), non ST elevation myocardial infarction (NSTEMI) 
(36.6%) and ST elevation myocardial infarction (STEMI) (31.4%). The risk factors and medical history differed between the indications (shown in 
table). Mortality was higher in STEMI patients at 1 year after PCI (9.6%) compared to NSTEMI (4.7%), unstable angina (2.2%) and stable CAD (2.0%), 
and at the long term between 1 and 6 years after PCI. The adjusted risk of stent thrombosis and heart failure was highest in STEMI patients.
conclusion: Mortality is higher after PCI for STEMI at short- and long term follow up. In order to reduce long term mortality after STEMI action for 
reduction of stent thrombosis and heart failure should be taken.
Table 
Variable
Stable CAD
N = 14820
Unstable angina
N = 7753
NSTEMI
N = 25779
STEMI
N = 22117
Age (years) (±SD)
≥ 80 years
66.4 (±9.7)
8.6%
65.9 (±10.5)
10.5%
67.7 (±11.1)
16.2%
66.8 (±12.0)
16.8%
Male gender 75.0% 71.7% 71.4% 70.7%
Current smoker 10.6% 15.2% 21.3% 28.0%
History myocardial infarction 24.2% 23.4% 19.4% 10.8%
1-year mortality adjusted HR (95% CI) 0.25 (0.22-0.29) 0.28 (0.24-0.33) 0.50 (0.46-0.54) 1.00 (ref.)
>1-year mortality adjusted HR (95% CI) 0.73 (0.66-0.81) 0.63 (0.56-0.71) 0.91 (0.84-0.99) 1.00 (ref.)
1-year stent thrombosis adjusted HR (95% CI) 0.46 (0.35-0.61) 0.58 (0.42-0.78) 0.86 (0.71-1.05) 1.00 (ref.)
>1-year stent thrombosis adjusted HR (95% CI) 0.29 (0.20-0.43) 0.48 (0.32-0.71) 0.56 (0.42-0.75) 1.00 (ref.)
1-year heart failure adjusted HR (95% CI) 0.43 (0.38-0.47) 0.50 (0.45-0.57) 0.71 (0.66-0.77) 1.00 (ref.)
>1-year heart failure adjusted HR (95% CI) 0.73 (0.64-0.84) 0.73 (0.63-0.86) 0.92 (0.82-1.03) 1.00 (ref.)
